Všem členům EAHP je zasílán e-mailem EAHP EU monitor v podobě pdf. dokumentu. jednotlivá čísla budeme pravidelně zveřejňovat na této stránce

The EAHP EU Monitor is distributed to EAHP members and is produced for the internal use of organisations, institutions, authorities and departments interested in developing hospital pharmacy and to establish a common pharmaceutical policy in Europe. It is entirely produced by EAHP, without external financial support.

EAHP EU Monitoring report (EUM) leden 2010(pdf. ke stažení)

In this issue you will read about:

New funding opportunities from the European Commission

What the Lisbon treaty changes for European policies and rules on health

WHO publication on hospital preparedness checklist for pandemic influenza

WHO support to pharmacy practice development through its EuroPharm Forum observatory

The Commissioner designate John Dalli

The OECD 2009 Health at a Glance report

News in brief, including:

1/ EU Member States try to sell surplus stocks of A(H1N1) vaccine

2/ Spain takes over rotating EU Presidency

3/ More involvement of patients and consumers in the European Medicines Agency - here

EAHP EU Monitor červen 2009 (pdf. ke stažení)

In this issue you will read about:
- Information on all clinical trials in Europe and paediatric trials undertaken worldwide are to be made public via the EudraCT database
- the Council discussions on patient rights to cross-border care and the issue of prior authorisation
- the Council debates on the pharmaceutical package and the issue of information on medecines
- the call to have medicines moved from the Industry sector of the European Commission to its Health Directorate General (see attached as well)
- pharmaceutical companies facing anti-trust probe

Please note that the next EU Monitor will be released in late September 2009. In the meantime, enjoy the summer.

In this issue you will read about:
- the European Court of Justice ruling stating that ownership and operation of pharmacies can be restricted to pharmacists alone,
- why the European Parliament is important for us,

- the development of a public private partnership to fund research on medicines
- the decision the EU health ministers are to make in the field of patient safety next week,
- the development of the H1N1 virus leading do a potential pandemic,
- the definition of advertising medicines, according to the European Court of Justice

EAHP EU Monitor květen 2009 (pdf. ke stažení)

Komentáře

B

i

u

Quote

Code

List

List item

URL

Jméno *
Mail
Opište kód   
ChronoComments by Joomla Professional Solutions

Přidat komentář